FindTrial
Sign In

Decreasing leakage of continuous femoral nerve catheter fixation with 2-octyl cyanoacrylate glue (Dermabond®): A randomized controlled study

Decreasing leakage of continuous femoral nerve catheter fixation with 2-octyl cyanoacrylate glue (Dermabond®): A randomized controlled study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200228002
Enrollment
Unknown
Registered
2020-02-28
Start date
2018-02-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total knee arthroplasty patients Total knee arthroplasty Catheter fixation 2&#45

Interventions

Surgical adhesive glue.,NA
Active Comparator Drug,Active Comparator Device
Dermabond®,Sterile stript

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Total knee arthroplasty patients Age 40-80 years ASA physical status 1-4

Exclusion criteria

Exclusion criteria: Localized infection at inguinal area Allergy to LA drug/glue/adhesive glue Refused to participate in the study

Design outcomes

Primary

MeasureTime frame
Catheter leakage 24 and 48 hr after the operation Percentage—

Secondary

MeasureTime frame
Catheter migration 24 and 48 hr after the operation Percentage—

Countries

Thailand

Contacts

Public ContactTheerawat Chalacheewa

Faculty of Medicine Ramathibodi Hospital

drtheerawat@gmail.com022011513

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026